Weekly Report: what happened at ACIU last week (0513-0517)?
Weekly Report · 1d ago
Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
Japan’s Takeda Pharmaceutical acquired global rights to an Alzheimer's therapy developed by AC Immune SA for $100 million upfront and up to $ billion in milestone payments. China's NMPA approved Augtyro as a treatment for adult patients with metastatic lung cancer. Zai Lab completed the enrollment process in a China Phase II trial of a potential psoriasis therapy.
Seeking Alpha · 1d ago
Buy Rating Justified by Strategic Partnerships and Promising Pipeline in AC Immune SA
TipRanks · 5d ago
SPWR, BIG and BOLT among pre-market losers
On the Move SPWR, BIG and BOLT among pre-market losers. Virpax Pharmaceuticals (VRPX) announces pricing of $ Million public offering. Big Lots (BIG) nears top of IBKR's most-active list.
Seeking Alpha · 6d ago
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Shares of DLocal Limited fell sharply in today's pre-market trading after the company reported weaker-than-expected first-quarter earnings. SunPower Corporation and Virgin Galactic Holdings, Inc. Also recorded losses. The Dow futures were slightly higher this morning, with the Dow gaining around 20 points.
Benzinga · 6d ago
APP, MGNX and CYCC among pre-market losers
On the Move APP, MGNX and CYCC among pre-market losers. Augmedix (AUGX) -38% reports Q1 results. Inotiv (NOTV) will report fiscal 2024 second quarter financial results on May 15, 2024.
Seeking Alpha · 05/14 12:25
Buy Rating Affirmed: AC Immune’s Promising Alzheimer’s Vaccine and Strategic Takeda Partnership
TipRanks · 05/14 10:26
ACIU Stock Earnings: AC Immune Misses EPS for Q1 2024
AC Immune reported earnings per share of -21 cents for the first quarter of 2024. The company did not report any revenue for the quarter. This was below the analyst estimate for EPS of -15 cents. AC Immune is a biopharmaceutical company based in New York.
Investorplace · 05/13 18:53
Gold Down Over 1%; AC Immune Shares Spike Higher
The Dow Jones index fell more than 50 points on Monday. Stocks traded mixed toward the end of trading. Information technology shares rose by 1%. GameStop Corp. Stock surged on Monday amid possible retail investor interest following a social media post by Roaring Kitty. Asian markets closed mixed on Monday, while European shares were mixed.
Benzinga · 05/13 18:32
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
AC Immune SA and Takeda Pharmaceutical Company Limited announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta. The company is developing an anti-Abeta active immunotherapy candidate for Alzheimer”s disease. ACImmune will receive an upfront payment of $100 million.
Benzinga · 05/13 17:46
FFIE, OGEN and CCLD among mid-day movers
On the Move FFIE, OGEN and CCLD among mid-day movers. CareCloud (CCLD) and Gamestop Corporation (GME) Gainers: CareCloud, Novavax and Tupperware Brands Corporation. Losers: TransCode Therapeutics and Koss Corp.
Seeking Alpha · 05/13 17:30
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Akoustis Technologies, Inc. Fell sharply in today's session following weak quarterly results. GameStop Corp. Shares jumped amid possible retail investor interest following a social media post by Roaring Kitty. AC Immune SA gained 31% to $ after the company reported first-quarter financial results.
Benzinga · 05/13 17:01
BUZZ-U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood
Investors awaited key inflation figures this week to gauge the likelihood of interest rate cuts in 2024. The Dow Jones Industrial Average and the S&P 500 hit record highs on Monday. GameStop Corp was one of the top percentage gainers on the New York Stock Exchange.
Reuters · 05/13 16:09
Crude Oil Surges Over 1%; Amprius Technologies Shares Plunge
Stocks traded mostly higher midway through trading on Monday, with the Nasdaq Composite gaining around 1%. GameStop Corp. Shares shot up 64% on Monday amid possible retail investor interest following a social media post by Roaring Kitty. Information technology shares rose by on Monday; communication services shares fell by . The Dow traded down to 39, while the NASDAQ rose to 16.
Benzinga · 05/13 16:00
AC Immune rockets 47% on Alzheimer's therapy deal with Takeda
AC Immune rockets 47% on Alzheimer's therapy deal with Takeda. The Swiss drug developer announced an option and licensing deal potentially worth over $2B for its Alzheimer's drug candidate. The drug is currently in Phase 2 testing. AC Immune also released its Q1 earnings report.
Seeking Alpha · 05/13 13:52
BUZZ-U.S. STOCKS ON THE MOVE-GameStop, AC Immune , Fulcrum Therapeutics
U.S. Stock indexes were set to open higher on Monday. Investors awaiting key inflation figures this week to gauge the likelihood of interest rate cuts in 2024. GameStop, AC Immune and Fulcrum Therapeutics were among the top three percentage gainers.
Reuters · 05/13 13:26
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
TransCode Therapeutics (NASDAQ:RNAZ) stock is sliding lower on Monday following its announcement of an upcoming annual shareholder meeting. Shares of RNAZ stock are down due to its plans for a reverse stock split. Investors will find more of the hottest stock market news for Monday. Safe & Green Development stock, AC Immune stock and Tevogen Bio stock are also down today.
Investorplace · 05/13 12:48
Alzheimer’s vaccine licensing deal boosts AC Immune
MarketWatch · 05/13 12:47
Market-Moving News for May 13th
GameStop shares trading higher amid possible retail investor interest. AC Immune shares are trading higher after the company reported Q1 financial results. Tevogen Bio Holdings shares are also trading higher. The company announced a deal to secure $50 million of financing for a potential Alzheimer's drug.
Benzinga · 05/13 12:42
Why Is Safe & Green Development (SGD) Stock Down 5% Today?
Safe & Green Development (NASDAQ:SGD) stock is down on Monday after the company filed a Form D with the SEC. The company is selling $ million in securities for the first time. Only 322,000 shares of the company’s stock have changed hands as of Monday morning. InvestorPlace offers insight into the latest stock market news for Monday. AC Immune and Tevogen Bio are the biggest pre-market stock movers this morning.
Investorplace · 05/13 12:31
Webull provides a variety of real-time ACIU stock news. You can receive the latest news about AC Immune through multiple platforms. This information may help you make smarter investment decisions.
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.